G02AD02 - Dinoprostone |
Propably not porphyrinogenic |
PNP |
Rationale
Endogenous prostaglandin. Low dose. Probably insignificant hepatic CYP metabolic load.
Chemical description
(DINOPROSTONE) Endogenous prostaglandin F2 alpha in vaginal gel (0.5- 2 mg /dose) used for cervix maturation and induction of labour. Short half life. Inactivated on passing the lungs. Metabolized by beta oxidation. Substrate for CYP 4F8. Inhibitor of CYPs 2B6 and 2C9.
Similar drugs
© NAPOS 2024